BACKGROUND AND PURPOSE: Atrial fibrillation is a common cause of stroke with a known preventive treatment. We compared poststroke recurrence and survival in Mexican Americans (MAs) and non-Hispanic whites (NHWs) with atrial fibrillation in a population-based study. METHODS: Using surveillance methods from the Brain Attack Surveillance in Corpus Christi Project, cases of ischemic stroke/transient ischemic attack with atrial fibrillation were prospectively identified from January 2000 to June 2008. Recurrent stroke and all-cause mortality were compared by ethnicity with survival analysis methods. RESULTS: A total of 236 patients were available (88 MAs, 148 NHWs). MAs were younger than NHWs, with no ethnic differences in severity of the first stroke or proportion discharged on warfarin. MAs had a higher risk of stroke recurrence than did NHWs (Kaplan-Meier estimates of survival free of stroke recurrence risk at 28 days and 1 year were 0.99 and 0.85 in MAs and 0.98 and 0.96 in NHWs, respectively; P=0.01, log-rank test), which persisted despite adjustment for age and sex (hazard ratio=2.46; 95% CI, 1.19-5.11). Severity of the recurrent stroke was higher in MAs than in NHWs (P=0.02). There was no ethnic difference in survival after stroke in unadjusted analysis or after adjusting for demographic and clinical factors (hazard ratio=1.03; 95% CI, 0.63-1.67). CONCLUSIONS: MAs with atrial fibrillation have a higher stroke recurrence risk and more severe recurrences than do NHWs but no difference in all-cause mortality. Aggressive stroke prevention measures focused on MAs are warranted.
BACKGROUND AND PURPOSE:Atrial fibrillation is a common cause of stroke with a known preventive treatment. We compared poststroke recurrence and survival in Mexican Americans (MAs) and non-Hispanic whites (NHWs) with atrial fibrillation in a population-based study. METHODS: Using surveillance methods from the Brain Attack Surveillance in Corpus Christi Project, cases of ischemic stroke/transient ischemic attack with atrial fibrillation were prospectively identified from January 2000 to June 2008. Recurrent stroke and all-cause mortality were compared by ethnicity with survival analysis methods. RESULTS: A total of 236 patients were available (88 MAs, 148 NHWs). MAs were younger than NHWs, with no ethnic differences in severity of the first stroke or proportion discharged on warfarin. MAs had a higher risk of stroke recurrence than did NHWs (Kaplan-Meier estimates of survival free of stroke recurrence risk at 28 days and 1 year were 0.99 and 0.85 in MAs and 0.98 and 0.96 in NHWs, respectively; P=0.01, log-rank test), which persisted despite adjustment for age and sex (hazard ratio=2.46; 95% CI, 1.19-5.11). Severity of the recurrent stroke was higher in MAs than in NHWs (P=0.02). There was no ethnic difference in survival after stroke in unadjusted analysis or after adjusting for demographic and clinical factors (hazard ratio=1.03; 95% CI, 0.63-1.67). CONCLUSIONS: MAs with atrial fibrillation have a higher stroke recurrence risk and more severe recurrences than do NHWs but no difference in all-cause mortality. Aggressive stroke prevention measures focused on MAs are warranted.
Authors: Dawn M Bravata; Shih-Yieh Ho; Lawrence M Brass; John Concato; Jeanne Scinto; Thomas P Meehan Journal: Stroke Date: 2003-02-20 Impact factor: 7.914
Authors: Lynda D Lisabeth; Melinda A Smith; Devin L Brown; Lemuel A Moyé; Jan M H Risser; Lewis B Morgenstern Journal: Ann Neurol Date: 2006-10 Impact factor: 10.422
Authors: Darin B Zahuranec; Devin L Brown; Lynda D Lisabeth; Nicole R Gonzales; Paxton J Longwell; Melinda A Smith; Nelda M Garcia; Lewis B Morgenstern Journal: Crit Care Med Date: 2009-10 Impact factor: 7.598
Authors: Paisith Piriyawat; Miriam Smajsová; Melinda A Smith; Sanjay Pallegar; Areej Al-Wabil; Nelda M Garcia; Jan M Risser; Lemuel A Moyé; Lewis B Morgenstern Journal: Am J Epidemiol Date: 2002-12-01 Impact factor: 4.897
Authors: Albert Yuh-Jer Shen; Janis F Yao; Somjot S Brar; Michael B Jorgensen; Xunzhang Wang; Wansu Chen Journal: Stroke Date: 2008-07-17 Impact factor: 7.914
Authors: Darin B Zahuranec; Lynda D Lisabeth; Jonggyu Baek; Eric E Adelman; Nelda M Garcia; Erin C Case; Morgan S Campbell; Lewis B Morgenstern Journal: J Health Dispar Res Pract Date: 2017
Authors: Claudia Jacova; Lesly A Pearce; Ana M Roldan; Antonio Arauz; Jorge Tapia; Raymond Costello; Leslie A McClure; Robert G Hart; Oscar R Benavente Journal: Int J Stroke Date: 2015-06 Impact factor: 5.266
Authors: Dagmar F Hernandez-Suarez; Stuart A Scott; Matthew I Tomey; Kyle Melin; Angel Lopez-Candales; Charlotte E Buckley; Jorge Duconge Journal: Ther Adv Cardiovasc Dis Date: 2017-07-04
Authors: Darin B Zahuranec; Lynda D Lisabeth; Brisa N Sánchez; Melinda A Smith; Devin L Brown; Nelda M Garcia; Lesli E Skolarus; William J Meurer; James F Burke; Eric E Adelman; Lewis B Morgenstern Journal: Neurology Date: 2014-05-16 Impact factor: 9.910
Authors: Karla Claudio-Campos; Aurora Labastida; Alga Ramos; Andrea Gaedigk; Jessicca Renta-Torres; Dariana Padilla; Giselle Rivera-Miranda; Stuart A Scott; Gualberto Ruaño; Carmen L Cadilla; Jorge Duconge-Soler Journal: Front Pharmacol Date: 2017-06-07 Impact factor: 5.810
Authors: Gene F Kwan; Danielle M Enserro; Emelia J Benjamin; Allan J Walkey; Renda Soylemez Wiener; Jared W Magnani Journal: Proclins Cardiol Date: 2018-12-14
Authors: Alvaro Avezum; Gustavo Bernardes de Figueiredo Oliveira; Rafael Diaz; Jesus Antonio Gonzalez Hermosillo; Jonas Oldgren; Ernesto Ferreiros Ripoll; Herbert Noack; Leopoldo Soares Piegas; Stuart J Connolly Journal: Open Heart Date: 2018-06-27